title: Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
abstract: The specificity of IGF2 promoter imprinting was examined in embryonal tissues and Wilms tumour. In several fetal tissues of approximately 12 weeks gestation, IGF2 was found to be monoallelically expressed from all IGF2 promoters i.e. P1, P2, P3 and P4. However, in tissues of slightly older gestation age (15-17 weeks) relaxation of imprinting at the P1 promoter was evident, although the P2-P4 promoters remained imprinted. These data indicate that early in embryogenesis a population of cells exists in which all IGF2 promoters are imprinted, but that as development proceeds the imprinting of the P1 promoter is relaxed. The pattern of IGF2 promoter imprinting was also analysed in Wilms tumour. In some tumours, the pattern of promoter imprinting was identical to that found in early fetal kidney, indicating that this tumour originates within early embryonic kidney tissue. In contrast, in tumours in which relaxation of imprinting had occurred, imprinting relaxation affected all IGF2 promoters. This aberrant pattern of promoter imprinting, which was not detected in fetal kidney, provides further evidence that pathological relaxation of IGF2 imprinting is involved in the genesis of Wilms tumour.
authors.affiliation: Department of Biochemistry, University of Otago, Dunedin, New Zealand.
authors.forename: T
authors.initials: T
authors.lastname: Taniguchi
authors.forename: A E
authors.initials: AE
authors.lastname: Schofield
authors.forename: J L
authors.initials: JL
authors.lastname: Scarlett
authors.forename: I M
authors.initials: IM
authors.lastname: Morison
authors.forename: M J
authors.initials: MJ
authors.lastname: Sullivan
authors.forename: A E
authors.initials: AE
authors.lastname: Reeve
mesh_terms: D000328:Adult; D001483:Base Sequence; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002880:Chromosomes, Human, Pair 11; D017931:DNA Primers; D005314:Embryonic and Fetal Development; D005091:Exons; D005260:Female; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics*; D007668:Kidney / Q000196:embryology / Q000473:pathology; D007680:Kidney Neoplasms / Q000196:embryology* / Q000235:genetics*; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011401:Promoter Regions, Genetic; D014158:Transcription, Genetic; D009396:Wilms Tumor / Q000196:embryology* / Q000235:genetics*
chemical_list: D017931:DNA Primers; D007335:Insulin-Like Growth Factor II